Tech Company Financing Transactions
NeuroTherapia Funding Round
On 8/6/2024, NeuroTherapia raised $12.3 million in Series B funding from Cleveland Clinic, Alzheimer's Drug Discovery Foundation and Brain Trust Accelerator Fund.
Transaction Overview
Company Name
Announced On
8/6/2024
Transaction Type
Venture Equity
Amount
$12,300,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for the continued clinical development of NTRX-07, an orally available cannabinoid receptor agonist, for the treatment of Alzheimer's disease (AD).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 Chagrin River Rd. PO Box 351
Gates Mills, OH 44040
USA
Gates Mills, OH 44040
USA
Phone
Website
Email Address
Overview
NeuroTherpia, Inc., founded in 2015 by Cleveland Clinic Innovations based on research by Drs. Mohamed Naguib and Joseph Foss, on new therapies for diseases with an underlying component of neuroinflammation. Initial research has led to the development of our lead compound NTRX-07.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tony Giordano
Founder
Joseph Foss
Browse more venture capital transactions:
Prev: 8/6/2024: Octane Lending venture capital transaction
Next: 8/6/2024: Hyperspace venture capital transaction
Share this article
About Database of VC Transactions
We document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs